AFT agrees three new deals for Maxigesic

2 October 2018 - Deborah Wilkes


New Zealand's AFT Pharmaceuticals has outlicensed its Maxigesic combination painkiller to three separate companies in Russia, Hong Kong and Taiwan.

Click tags below for more information on topics:


Annual Subscription Holder?

Sign in to continue reading.

Sign In

Back to Industry News

Share this page: